Tempostatin (halofuginone) - Grunenthal, Akashi Therap
AZD8233 - AstraZeneca
CIVI 007 - CiVi Biopharma
Leqvio (inclisiran) - Alnylam, Novartis
Praluent (alirocumab) - Sanofi, Regeneron
PF-07202954 - Pfizer
Repatha (evolocumab) - Amgen, Astellas
MK-4074 - Merck (MSD)
VK0612 - Viking Therap, Ligand
mongersen (GED-0301) - BMS
lerodalcibep (LIB003) - LIB Therap
clesacostat (PF-05221304) - Pfizer
MK-0616 - Merck (MSD), UCB
ION224 - Ionis
Firsocostat (GS-0976) - Gilead
etomoxir (MIQ-001) - Meta-IQ
PF-06427878 - Pfizer
http://www.ncbi.nlm.nih.gov/pubmed/38195542
 
Chao Wang; Dongming Xing; Jianfeng Wu; Jianxia Hu; Jie Wang; Meng Zhu; Miao Zhang; Minglu Hao; Shuangshuang Zhang; Weichao Hu; Wujun Chen; Xiaolei Liu; Xiaolin Wu; Yanhong Wang; Yingchun Shao; Yudong Wu; Zhu Guo
 
Jan 10, 2024
 
Prev Next